EL7.AI
Strategy BuilderCOT DataAdvanced NewsResearchNewEarnings CalendarEconomic Calendar
We use cookiesPrivacy Policy
EL7.AIEL7.AI

AI Financial Intelligence
Professional analysis of central bank decisions

© 2026 EL7.AI. All rights reserved.

Markets

  • News
  • Forex
  • Stocks
  • Crypto
  • Gold
  • Commodities
  • Indices
  • ETFs

Analysis

  • Fed
  • ECB
  • BLS
  • COT
  • Economic Calendar

Learn

  • Service Guide
  • Oil

Company

  • About
  • Contact
  • Data Methodology
  • AI Disclosure
  • Pricing
  • Enterprise
  • Terms
  • Privacy
  • Security
  • WhatsApp
Status data is currently unavailable

The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

Home
Stocks
Kazia Therapeutics Limited
KZIA

KZIA Kazia Therapeutics Ltd ADR

Kazia Therapeutics Ltd ADR · NASDAQ
Market Closed
10.39
▼ ⁦-4.33%⁩ (-0.47)
Market Cap$16.8M
Beta2.17
52w Low52w High
4.8617.40
Last Week
⁦-7.15%⁩
Last Month
⁦-23.38%⁩
Last 3 Months
⁦-8.86%⁩
Last Year
⁦+33.89%⁩
EL7 Factor Analysis
How we score this
Overall16
Poor — bottom quartile of the marketHigh FlyerF 2/9DistressBetter than 16% of Market stocks, per EL7's model
FactorScoreDistributionValueAvgRank
▸
Valuation
3
—17.6xBottom tier
▸
Growth
28
-98.2%▼7.1%Bottom tier
▸
Quality
100
—4.5%Top tier
▸
Safety
51
—2.6xAround median
▸
Capital Return
32
0.00%▼2.15%Bottom tier
▸
Momentum
55
74.7%▲2.3%Around median
▸
Sentiment
23
1▼3Bottom tier

Frequently Asked Questions

What is Kazia Therapeutics Limited stock?▼

Kazia Therapeutics Limited is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.

How can I invest in Kazia Therapeutics Limited?▼

You can buy Kazia Therapeutics Limited shares through a licensed brokerage. Research the company's financials before investing.

What are the key metrics for evaluating Kazia Therapeutics Limited?▼

Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.

Does Kazia Therapeutics Limited pay dividends?▼

Dividend policies vary by company. Check the dividends section on the stock page for the payout history.

What are the risks of investing in Kazia Therapeutics Limited?▼

Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.

Fair Value
Low confidenceCurrent price$10
Analyst target · 1 analysts
$31
—
Range ⁦$25–$40⁩
vs
DCF (estimate)
N/A (negative FCF)

Estimates — analyst targets and a simplified DCF, not investment advice.

Compare in the screener

AI analysis from the earnings call, financials and news

Analyst Consensus

This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.

Price Target· 1 analysts setting price target
$31.50
⁦+203.2%⁩
Current Price $10.39·Median $30.50
Low
$25.00
High
$40.00
Current price
$10.39
Average target
$31.50
Street summary

A slight increase in the target with limited confidence

Bullish tilt

The consensus price target rose to 31.5 from 30.33 over the last 30 days, an increase of 1.17 or 3.86%, while remaining unchanged over the last 7 days. The current range is between 25 and 40, with an average of 31.5 and a median of 30.5, but coverage is limited to one analyst; therefore, the differences do not reflect a true breadth of opinions among multiple analysts. Compared with the current price of 12.01, the targets indicate an optimistic outlook in terms of the target valuation level.

As of 2026-09-08
Revisions momentum · 30d
⁦+5.0%⁩
Average rating
★ 4.33
Buy
Analyst coverage
6
Buy conviction
100%
High
Rating activity · 30d
0↑ · 0↓
Target dispersion
144%
Wide
Analyst ratings over time6 analysts rating
2
4
Strong BuyBuyHoldSellStrong Sell
Rating trend — last 12 months4.67 → 4.33
Recent analyst moves
  • = Reiterate2026-09-01
    BTIG
    Buy
  • = Reiterate2026-07-01
    BTIG
    Buy
  • = Reiterate2026-06-11
    Lake Street
    Buy
Premium content
Financial Analysis
|